X
19
Biogen, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and WHO-GMP.
One of their notable products is NATALIZUMAB, with a corresponding application number 125104 and regulatory information .
proudly manufactured in the
Biogen's TYSABRI VIAL; SINGLE-USE, medication with 300MG of NATALIZUMAB.